Associate Professor Washington University Saint Louis, MO
Disclosure(s):
Colleen McEvoy, MD,: Aerovate Therapeutics, Inc: Clinical Trial Investigator (Ongoing); Janssen Pharmaceuticals: Advisory Board (Terminated); Merck: Advisory Board (Ongoing), Clinical Trial Investigator (Ongoing); United Therapeutics: Advisory Board (Ongoing), Clinical Trial Investigator (Ongoing), Fees for Non-CME Services Received Directly from Commercial Interest or their Agents (e.g., speakers' bureaus) (Ongoing)
Emerging targeted therapies for the treatment of cancer have been associated with a number of severe and life-threatening side effects. This session will review associated toxicities such as hypersensitivity reactions, cytokine release syndrome, and other notable toxicities.
